SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUIDOBONI, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 603
AS - Asia 305
EU - Europa 173
SA - Sud America 8
Totale 1.089
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 600
SG - Singapore 135
CN - Cina 115
IT - Italia 63
DE - Germania 38
ID - Indonesia 38
UA - Ucraina 25
GB - Regno Unito 12
AT - Austria 9
FR - Francia 8
FI - Finlandia 7
IN - India 6
TR - Turchia 6
BR - Brasile 4
SE - Svezia 4
CA - Canada 3
NL - Olanda 3
BE - Belgio 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
EC - Ecuador 1
HK - Hong Kong 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LT - Lituania 1
PE - Perù 1
RS - Serbia 1
TW - Taiwan 1
Totale 1.089
Salva come PNG Salva come JPEG
Città #
Santa Clara 255
Singapore 108
Jakarta 38
Woodbridge 37
Fairfield 36
Houston 33
Jacksonville 26
Nuremberg 19
Ashburn 16
Dearborn 16
Shanghai 13
Ferrara 11
Milan 11
Seattle 11
Cambridge 10
Chandler 10
Los Angeles 9
Wilmington 9
Bologna 7
Nanjing 6
Boardman 5
Falkenstein 5
Izmir 5
Princeton 5
San Diego 5
Vienna 5
Ann Arbor 4
Forlì 4
Nanchang 4
Beijing 3
Delhi 3
Frankfurt am Main 3
London 3
Brescia 2
Brookline 2
Clifton 2
Council Bluffs 2
Ferrara di Monte Baldo 2
Guangzhou 2
Hebei 2
Lappeenranta 2
Monza 2
Nervesa della Battaglia 2
New York 2
Shenyang 2
Taiyuan 2
Toronto 2
Amman 1
Amsterdam 1
Belgrade 1
Bishkek 1
Bremen 1
Brussels 1
Chicago 1
Chiswick 1
Crevalcore 1
Curitiba 1
Fuzhou 1
Guayaquil 1
Hefei 1
Helsinki 1
Hong Kong 1
Kunming 1
Lima 1
Lyon 1
Minsk 1
Ningbo 1
Ottawa 1
Owensboro 1
Rome 1
Rondonópolis 1
Sala Baganza 1
San Francisco 1
San Mateo 1
Springfield 1
São Paulo 1
Tappahannock 1
Tel Aviv 1
Teresópolis 1
Tianjin 1
Xuzhou 1
Zhengzhou 1
Totale 798
Salva come PNG Salva come JPEG
Nome #
Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis 117
The long-term prognostic impact of sentinel lymph node biopsy in patients with primary cutaneous melanoma: a prospective study with 10-year follow-up 94
Effect of vaccination with autologous tumor-loaded dendritic cells on intratumoral regulatory T cells in metastatic melanoma patients 73
Prognostic value of microsatellite instability and intratumor activated cytotoxic lymphocytes in colon cancer 70
Retinoic acid inhibits the proliferative response induced by CD40 activation and interleukin-4 in mantle cell lymphoma 58
Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center 22
Comparative efficacy and safety of targeted therapies for BRAF-mutant unresectable or metastatic melanoma: Results from a systematic literature review and a network meta-analysis 22
Efficacy of ipilimumab plus nivolumab or ipilimumab plus fotemustine vs fotemustine in patients with melanoma metastatic to the brain: Primary analysis of the phase III NIBIT-M2 trial 22
Anti-PD1 antibodies in patients aged ≥ 75 years with metastatic melanoma: A retrospective multicentre study 22
Sequencing of Ipilimumab Plus Nivolumab and Encorafenib Plus Binimetinib for Untreated BRAF-Mutated Metastatic Melanoma (SECOMBIT): A Randomized, Three-Arm, Open-Label Phase II Trial 20
Primary Analysis and 4-Year Follow-Up of the Phase III NIBIT-M2 Trial in Melanoma Patients With Brain Metastases 19
Dendritic cell vaccination for metastatic melanoma: a 14-year monoinstitutional experience 19
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 18
Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma 18
Near-Complete Response to Osimertinib for Advanced Non-Small-Cell Lung Cancer in a Pretreated Patient Bearing Rare Compound Exon 20 Mutation (S768I + V774M): A Case Report 18
ILLUMINATE 301: A randomized phase III study of tilsotolimod in combination with ipilimumab compared with ipilimumab alone in patients with advanced melanoma following progression on or after anti-PD-1 therapy 17
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative study 17
ML Models Built Using Clinical Parameters and Radiomic Features Extracted from 18F-Choline PET/CT for the Prediction of Biochemical Recurrence after Metastasis-Directed Therapy in Patients with Oligometastatic Prostate Cancer 17
Cancer Bio-Immunotherapy in Siena": Twelfth Meeting of the Network Italiano per la Bioterapia dei Tumori (NIBIT), Siena, Italy, October 9-11, 2014 17
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial 17
Bacteria-eradicating therapy with doxycycline in ocular adnexal MALT lymphoma: A multicenter prospective trial 16
First-line, Fixed-Duration Nivolumab plus Ipilimumab Followed by Nivolumab in Clinically Diverse Patient Populations With Unresectable Stage III or IV Melanoma: CheckMate 401 15
Melanoma metastasis mimicking gastric cancer: a challenge that starts from diagnosis 15
First report of efficacy and safety from the phase II study SECOMBIT (SEquential COMBo Immuno and Targeted Therapy study) 15
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: Final data 14
Radiotherapy and High-Dose Interleukin-2: Clinical and Immunological Results of a Proof of Principle Study in Metastatic Melanoma and Renal Cell Carcinoma 14
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy) 14
Dendritic cell-based vaccine in advanced melanoma: update of clinical outcome 13
Correspondence re: Samowitz et al., Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol. Biomark. Prev., 10 : 917-923, 2001 13
Association between Helicobacter pylori infection and MALT-type lymphoma of the ocular adnexa: clinical and therapeutic implications 13
Complementary vaccination protocol with dendritic cells pulsed with autologous tumour lysate in patients with resected stage III or IV melanoma: protocol for a phase II randomised trial (ACDC Adjuvant Trial). 13
Appropriate use of tumour biomarkers for treatment with innovative drugs: A retrospective study 13
Combined and sequential expression of p53, Rb, Ras and Bcl-2 in bronchial preneoplastic lesions 12
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma 12
Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases 12
Association of CTLA-4 Gene Variants with Response to Therapy and Long-term Survival in Metastatic Melanoma Patients Treated with Ipilimumab: An Italian Melanoma Intergroup Study 12
Functional up-regulation of human leukocyte antigen class I antigens expression by 5-aza-2'-deoxycytidine in cutaneous melanoma: immunotherapeutic implications 12
Dabrafenib-trametinib combination in 'field-practice': an Italian experience 11
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab 11
Activation of infiltrating cytotoxic T lymphocytes and lymphoma cell apoptotic rates in gastric MALT lymphomas - Differences between high-grade and low-grade cases 11
Chlamydia infection and lymphomas: Association beyond ocular adnexal lymphomas highlighted by multiple detection methods 11
Therapeutic efficacy of ipilimumab, an anti-CTLA-4 monoclonal antibody, in patients with metastatic melanoma unresponsive to prior systemic treatments: clinical and immunological evidence from three patient cases 11
Malignant Pleural Mesothelioma: State-of-the-Art on Current Therapies and Promises for the Future 11
Baseline neutrophils and derived neutrophil-to-lymphocyte ratio: prognostic relevance in metastatic melanoma patients receiving ipilimumab 10
Sequential immunotherapy and targeted therapy for metastatic BRAF V600 mutated melanoma: 4-year survival and biomarkers evaluation from the phase II SECOMBIT trial 10
Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study 10
Outcomes in patients with BRAFV600–mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinib 9
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profile 9
Unexpected High Response Rate to Traditional Therapy after Dendritic Cell-Based Vaccine in Advanced Melanoma: Update of Clinical Outcome and Subgroup Analysis 8
Vaccination with autologous dendritic cells loaded with autologous tumor lysate or homogenate combined with immunomodulating radiotherapy and/or preleukapheresis IFN-alpha in patients with metastatic melanoma: a randomised "proof-of-principle" phase II study 7
High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability 7
IDIOTYPIC VACCIN 7
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma 7
Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response 7
Isolated bone marrow manifestation of HIV-associated Hodgkin lymphoma 6
High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance 6
Retinoic acid inhibits IL-6-dependent but not constitutive STAT3 activation in Epstein-Barr virus-immortalized B lymphocytes 6
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study 6
Low-dose temozolomide before dendritic-cell vaccination reduces (specifically) CD4(+)CD25(++)Foxp3(+) regulatory T-cells in advanced melanoma patients 6
Ipilimumab in advanced melanoma: reports of long-lasting responses 6
IGKV3 Proteins as Candidate "Off-the-Shelf" Vaccines for Kappa-Light Chain-Restricted B-Cell Non-Hodgkin Lymphomas 6
Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas 6
Melanoma vaccines in development 5
Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy 5
Latent membrane protein 1 deletion mutants accumulate in Reed-Sternberg cells of human immunodeficiency virus-related Hodgkin's lymphoma 5
Rituximab in patients with mucosal-associated lymphold tissue-type lymphoma of the ocular adnexa 5
Retinoic acid stabilizes p27(Kip1) in EBV-immortalized lymphoblastoid B cell lines through enhanced proteasome-dependent degradation of the p45(Skp2) and Cks1 proteins 5
Epigenetic remodelling of DNA in cancer 5
Skewing effect of sulprostone on dendritic cell maturation compared with dinoprostone 5
IL-17/IL-10 double-producing T cells: new link between infections, immunosuppression and acute myeloid leukemia 5
MicroRNAs and dendritic cell-based vaccination in melanoma patients 5
Undifferentiated nasopharyngeal carcinoma from a nonendemic area: Protective role of HLA allele products presenting conserved EBV epitopes 5
Liver Metastases from Melanoma: Hepatic Intra-Arterial Chemotherapy. A Retrospective Study 5
Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type 5
Infectious agents in mucosa-associated lymphoid tissue-type lymphomas: Pathogenic role and therapeutic perspectives 5
Increased frequency of acute reactions to iodinated contrast media in cancer patients treated with anti-CTLA-4 immunomodulatory antibodies. 5
Totale 1.200
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 96
Totale 13.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 0 9 6 11 2 2
2020/202153 7 5 2 6 0 7 0 8 0 7 9 2
2021/202257 4 4 1 2 1 2 1 9 3 4 3 23
2022/202351 6 4 1 4 9 4 1 3 8 1 8 2
2023/2024197 3 6 3 2 0 50 0 51 0 4 19 59
2024/2025636 38 105 69 7 189 166 31 31 0 0 0 0
Totale 1.200